TradingView
RocketTickers
9 אפר׳ 2019 21:31

FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment לונג

NASDAQ:AMGN1D
Amgen Inc.NASDAQ

תיאור

⋅
AMGN: Amgen
2019-04-09 15:57:00
FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture - PR Newswire
Beyond Technical Analysis
עוד